Sonoma Pharmaceuticals Inc (SNOA):医療機器:M&Aディール及び事業提携情報

【英語タイトル】Sonoma Pharmaceuticals Inc (SNOA) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C11398)・商品コード:DATA904C11398
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:39
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥55,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥83,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for advanced wound management, nursing home and home healthcare, wound and skin care, among others. It offers women’s healthcare products, Microcyn skin and wound care products, Regenacyn advanced scar management hydrogel and animal healthcare, among others. Sonoma develops its products based on shelf-stable microcyn technology platform. The company sells its products through OTC stores. The company operates in the Netherlands and the US. Sonoma is headquartered in Petaluma, California, the US.

Sonoma Pharmaceuticals Inc (SNOA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sonoma Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sonoma Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Partnerships 10
Oculus Innovative Sciences Enters into Agreement with Lipogrid 10
Oculus Innovative Sciences Enters Into Licensing Agreement With More Pharma 11
Equity Offering 12
Sonoma Pharma Prices Public Offering of Units 12
Sonoma Pharma Raises USD5 Million in Public Offering of Shares 13
Oculus Innovative Sciences Completes Public Offering Of Common Stock For US$3.5 Million 15
Oculus Innovative Sciences Completes Private Placement Of Preferred Stock For US$1 Million 16
Oculus Innovative Sciences Completes Private Placement Of Shares For US$2 Million 17
Sonoma Pharmaceuticals Inc – Key Competitors 18
Sonoma Pharmaceuticals Inc – Key Employees 19
Sonoma Pharmaceuticals Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Business Unit 20
Recent Developments 22
Financial Announcements 22
Nov 08, 2018: Sonoma Pharmaceuticals reports record revenue in second quarter FY 2019 22
Aug 08, 2018: Sonoma Pharmaceuticals reports first quarter fy 2019 financial results 24
Jun 13, 2018: Sonoma Pharmaceuticals Announces Fiscal Year And Fourth Quarter 2018 Financial Results 25
Feb 07, 2018: Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46% 27
Nov 09, 2017: Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of $4.3 Million 29
Aug 08, 2017: Sonoma Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 31
Jun 05, 2017: Sonoma Pharmaceuticals Reports Financial Results for Fourth Quarter and Fiscal Year 2017 32
Feb 09, 2017: Sonoma Pharmaceuticals Reports Financial Results for Fiscal Third Quarter 2017 34
Corporate Communications 36
Sep 19, 2018: Sonoma Pharmaceuticals names Phillipe Weigerstorfer as Board Director 36
May 08, 2018: Sonoma Pharmaceuticals Names Marc Umscheid Chief Operating Officer 37
Jan 31, 2017: Sonoma Pharmaceuticals Appoints Marc Umscheid As Chief Strategy And Marketing Officer 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Sonoma Pharmaceuticals Inc, Medical Equipment, Key Facts, 2018 2
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sonoma Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sonoma Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Oculus Innovative Sciences Enters into Agreement with Lipogrid 10
Oculus Innovative Sciences Enters Into Licensing Agreement With More Pharma 11
Sonoma Pharma Prices Public Offering of Units 12
Sonoma Pharma Raises USD5 Million in Public Offering of Shares 13
Oculus Innovative Sciences Completes Public Offering Of Common Stock For US$3.5 Million 15
Oculus Innovative Sciences Completes Private Placement Of Preferred Stock For US$1 Million 16
Oculus Innovative Sciences Completes Private Placement Of Shares For US$2 Million 17
Sonoma Pharmaceuticals Inc, Key Competitors 18
Sonoma Pharmaceuticals Inc, Key Employees 19
Sonoma Pharmaceuticals Inc, Other Locations 20
Sonoma Pharmaceuticals Inc, Subsidiaries 20
Sonoma Pharmaceuticals Inc, Business Unit 20

List of Figures
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★調査レポート[Sonoma Pharmaceuticals Inc (SNOA):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C11398)販売に関する免責事項を必ずご確認ください。
★調査レポート[Sonoma Pharmaceuticals Inc (SNOA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆